Pharmaceutical

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the BoardVancouver, British Columbia and Rehovot, Israel--(Newsfile…

11 months ago

Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

Live webcast on Wednesday, January 29th at 2:00 PM ETISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.…

11 months ago

Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies

Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment…

11 months ago

New Natural Sleep Aid Innovation Combines Traditional Ingredients With Modern Science

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 22, 2025 / Perfiby, a California-based wellness company, today announced the launch…

11 months ago

Biodexa Strengthens Management Team – Appointment of Dr Gary A. Shangold as Chief Medical Officer

January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC…

11 months ago

KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus

The hospital location positions KindlyMD to expand its core service offerings into Weber County SALT LAKE CITY, UT / ACCESS…

11 months ago

Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE…

11 months ago

Ursamin Pilots Achieve Measurable Results in Streamlining Care Coordination Workflows

Pilot studies deliver significant time savings and streamline workflows for primary care teams. FAYETTEVILLE, NY / ACCESS Newswire / January…

11 months ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage…

11 months ago